Aptevo Therapeutics Inc. APVO
1.24 USD -0.03 (-2.36%)
At closeNov 6, 2026, 7:58 PM EST
1.25 +0.01 +0.81%
After hours · Nov 6, 7:58 PM ET
1.20 Day range 1.32
1.24 52-week range 28.08
- YTD
- -86.85%
- 1 year
- -95.31%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -26.31M | -24.60M | -28.88M | -28.64M | -21.40M | |
| -25.97M | -24.13M | -17.41M | 8.03M | -28.46M | |
| -87.27 | -31,460.23 | -834,059.00 | 920,146.00 | -3,557,506.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 21.62M | 8.71M | 16.90M | 22.64M | 46.30M | |
| 27.19M | 15.59M | 24.84M | 34.22M | 56.60M | |
| 9.81M | 10.84M | 12.62M | 16.24M | 55.38M | |
| 4.63M | 5.40M | 5.40M | 9.54M | 16.71M | |
| 17.38M | 4.75M | 12.22M | 17.97M | 1.22M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -25.59M | -23.79M | -11.73M | -21.02M | -21.68M | |
| 38.50M | 15.60M | 6.00M | -2.62M | 26.16M | |
| 12.90M | -8.19M | -5.73M | -23.67M | 3.77M |
